Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001
-
Shares outstanding
-
302,717,464
-
Total 13F shares
-
204,923,540
-
Share change
-
-20,805,225
-
Total reported value
-
$1,190,613,817
-
Put/Call ratio
-
95%
-
Price per share
-
$5.80
-
Number of holders
-
197
-
Value change
-
-$110,429,204
-
Number of buys
-
88
-
Number of sells
-
101
Institutional Holders of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) as of Q3 2022
As of 30 Sep 2022,
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) was held by
197 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
204,923,540 shares.
The largest 10 holders included
ARK Investment Management LLC, Jackson Square Partners, LLC, VANGUARD GROUP INC, BlackRock Inc., Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., Capital International Investors, T. Rowe Price Investment Management, Inc., Bellevue Group AG, and STATE STREET CORP.
This page lists
201
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.